Summary:
Attention: Is Your Mild to Moderate Ulcerative Colitis not Adequately Controlled?
If you are age 18 or older, you may qualify for a clinical research study of the safety and effectiveness of a drug designed to treat ulcerative colitis.
Qualified Participants Must:
• Be age 18 or older
• Be taking mesalamine for at least six weeks prior to joining the study
•Have active mild to moderate ulcerative colitis
• NOT suffer from Crohn’s disease
Qualified Participants May Receive:
Study-related medicine or placebo at no-cost
, study-related medical care at no-cost
as well as compensation up to $510 for time and travel.